Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: A prospective cohort study

Urologia Internationalis

Volumn 94, Issue 1, 2015, Pages 37-44

  Aziz, Atiqullah ^a   Madersbacher, Stephan ^b   Otto, Wolfgang ^a   Mayr, Roman ^a   Comploj, Evi ^c   Pycha, Armin ^c   Denzinger, Stefan ^a   Fritsche, Hans Martin ^a   Burger, Maximilian ^a   Gierth, Michael ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b KAISER FRANZ JOSEF HOSPITAL   (Austria)

^c CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

Carcinoma; Referrals; Sex characteristics; Transitional cell; Urinary bladder neoplasms

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER TUMOR; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; COHORT ANALYSIS; COMPARATIVE STUDY; CONSULTATION; CYSTALGIA; CYSTOSCOPY; DYSURIA; FEMALE; GENERAL PRACTITIONER; HEMATURIA; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; PATIENT REFERRAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SEX DIFFERENCE; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; URINARY TRACT INFECTION; UROLOGIST; UROTHELIAL CARCINOMA OF THE BLADDER; VALIDATION STUDY; AUSTRIA; CARCINOMA; CLINICAL TRIAL; COMPLICATION; HEALTH CARE DISPARITY; ITALY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PREDICTIVE VALUE; PRIMARY HEALTH CARE; PROGNOSIS; RISK FACTOR; SPECIALIZATION; TIME; TRENDS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

AGED; AUSTRIA; CARCINOMA; CYSTOSCOPY; DYSURIA; FEMALE; GENERAL PRACTITIONERS; HEALTHCARE DISPARITIES; HUMANS; ITALY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; REFERRAL AND CONSULTATION; RISK FACTORS; SEX FACTORS; SPECIALIZATION; TIME FACTORS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84923592236     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000363334     Document Type: Article

References (29)

1. Scosyrev E, Trivedi D, Messing E: Female bladder cancer: incidence, treatment, and outcome. Curr Opin Urol 2010; 20: 404-408.
2. Burger M, Catto JW, Dalbagni G, et al: Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013; 63: 234-241.
3. Cardenas-Turanzas M, Cooksley C, Pettaway CA, et al: Comparative outcomes of bladder cancer. Obstet Gynecol 2006; 108: 169-175.
4. Fajkovic H, Halpern JA, Cha EK, et al: Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 2011; 29: 457-463.
5. Henning A, Wehrberger M, Madersbacher S, Pycha A, Martini T, Comploj E, Jeschke K, Tripolt C, Rauchenwald M: Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer. BJU Int 2013; 112: 68-73.
6. Edge SB, Byrd DR, Compton CC, et al: American Joint Committee on Cancer (AJCC) Staging Manual, ed 7. New York, Springer, 2010.
7. Messing EM, Young TB, Hunt VB, et al: Urinary tract cancers found by homescreening with hematuria dipsticks in healthy men over 50 years of age. Cancer 1989; 64: 2361-2367.
8. Mariani AJ, Mariani MC, Macchioni C, et al: The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol 1989; 141: 350-355.
9. Nieder AM, Lotan Y, Nuss GR, et al: Are patients with hematuria appropriately referred to urology. A multi-institutional questionnaire based survey. Urol Oncol 2010; 28: 500-503.
10. Mansson A, Anderson H, Colleen S: Time lag to diagnosis of bladder cancer-influence of psychosocial parameters and level of healthcare provision. Scand J Urol Nephrol 1993; 27: 363-369.
11. Yafi FA, Aprikian AG, Tanguay S, et al: Patients with microscopic and gross hematuria: practice and referral patterns among primary care physicians in a universal health care system. Can Urol Assoc J 2011; 5: 97-101.
12. Johnson EK, Diagnaul S, Zhang Y, et al: Patterns of hematuria referral to urologists: does a gender disparity exist. Urology 2008; 72: 498-502.
13. May M, Nitzke T, Helke C, Vogler H, Hoschke B: Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. Scand J Urol Nephrol 2004; 38: 231-235.
14. Kluth LA, Fajkovic H, Xylinas E, et al: Female gender is associated with higher risk of disease recurrence in patients with primary T1 highgrade urothelial carcinoma of the bladder. World J Urol 2013; 31: 1029-1036.
15. Fernandez-Gomez J, Madero R, Solsona E, et al: Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. J Urol 2009; 182: 2195-2203.
16. Palou J, Sylvester RJ, Faba OR, Parada R, Pena JA, Algaba F, Villavicencio H: Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guerin. Eur Urol 2012; 62: 118-125.
17. Keck B, Ott OJ, Haberle L, et al: Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio-or radiochemotherapy. World J Urol 2013; 31: 1023-1028.
18. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al: Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2,596 patients from seven EORTC trials. Eur Urol 2006; 49: 466-475.
19. Kluth LA, Rieken M, Xylinas E, et al: Genderspecific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. Eur Urol DOI: 10.1016/ j.eururo.2013.11.040.
20. Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW, Witjes JA, Kiemeney LA: Gender differences in stage-adjusted bladder cancer survival. Urology 2000; 55: 876-880.
21. Horstmann M, Witthuhn R, Falk M, Stenzl A: Gender-specific differences in bladder cancer: a retrospective analysis. Gend Med 2008; 5: 385-394.
22. May M, Stief C, Brookman-May S, et al: Gender-dependent cancer-specific survival following radical cystectomy. World J Urol 2012; 30: 707-713.
23. Otto W, May M, Fritsche HM, et al: Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2,500 patients with urothelial carcinoma of the bladder. Gend Med 2012; 9: 481-489.
24. Tetu B: Diagnosis of urothelial carcinoma from urine. Mod Pathol 2009; 2: 53-59.
25. Bassi PF, De Marco V, De Lisa A, et al: Noninvasive diagnostic tests for bladder cancer: a review of the literature. Urol Int 2005; 75: 193-200.
26. Gutierrez Banos JL, Rebollo Rodrigo MH, Antolin Juarez FM, Martin Garci a B: NMP 22, BTA stat test and cytology in the diagnosis of bladder cancer: a comparative study. Urol Int 2001; 66: 185-190.
27. Sagnak L, Ersoy H, Gucuk O, et al: Diagnostic value of a urine-based tumor marker for screening lower urinary tract in low-risk patients with asymptomatic microscopic hematuria. Urol Int 2011; 87: 35-41.
28. Vom Dorp F, Pal P, Tschirdewahn S, et al: Correlation of pathological and cytologicalcytometric grading of transitional cell carcinoma of the urinary tract. Urol Int 2011; 86: 36-40.
29. Falebita OA, Lee G, Sweeney P: Urine cytology in the evaluation of urological malignancy revisited: is it still necessary. Urol Int 2010; 84: 45-49.